跳至主要内容
临床试验/NCT04580628
NCT04580628已完成不适用

Thuflep/SOLEP : Initial Experience and Results of Prostate Laser Enucleation With Thulium-fiber Laser (TFL)

Clinique Saint-Hilaire1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Measuring the evolution of Urinary Symptoms Rated by the IPSS Score after prostate laser enucleation with TFL

研究概览

简要总结

Thuflep TLF: initial experience and results of prostate laser enucleation with fibrous thulium laser (TLF)

详细描述

While prostate laser enucleation is being confirmed as the new gold standard for surgical management of benign prostate hypertrophy, the holmium:Yag laser is currently the most widely used. A new laser technology, the fibrous thulium laser (TFL), has recently appeared with clearly superior results for lithotripsy. The question therefore arises of the surgical and functional results of the use of fibrous thulium for prostate enucleation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients superior or equal to 18 years old
  • Benign Prostate Hypertrophy ( more than 30cc.)
  • Indication to surgical treatment
  • No contraindication for surgery
  • No opposition to participating in the study

排除标准

  • Evidence of urethral stenosis
  • Evidence of a bladder tumour
  • Evidence of prostate cancer known or confirmed by prostate biopsies if suspected
  • Known neurological bladder
  • Refusal to participate

结局指标

主要结局

Measuring the evolution of Urinary Symptoms Rated by the IPSS Score after prostate laser enucleation with TFL

时间窗: MONTH 12

self reported International Prostate Symptom Score (IPSS) From 0 (no symptom) to 35 (maximum symptoms)

次要结局

  • duration of intervention(POST SURGERY HOUR 24)
  • max flow assessment(MONTH 1)
  • quality of life assessment(MONTH 1)
  • bloodloss assessment(Day 1)
  • Rate of post-operative complications(MONTH 6)
  • erectile dysfunction assessment(MONTH 1)
  • prostatic specific antigen in ng/mL level evolution(MONTH 1)
  • Measuring the evolution of Urinary Symptoms Rated by the IPSS Score after prostate laser enucleation with TFL(MONTH 6)
  • PATIENT GLOBAL IMPRESSION OF SEVERITY(MONTH 1)
  • post-void residual (PVR) urine test(MONTH 1)
  • PATIENT GLOBAL IMPRESSION OF IMPROVEMENT(MONTH 1)
  • urinary incontinence Assessment(MONTH 1)

研究者

发起方
Clinique Saint-Hilaire
申办方类型
Other
责任方
Principal Investigator
主要研究者

MALVAL Benoit

Principal Investigator, Doctor in urology department

Clinique Saint-Hilaire

研究点 (1)

Loading locations...

相似试验